JPMorgan Chase & Co. set a €38.90 ($45.23) price target on Siemens Healthineers (ETR:SHL) in a research note issued to investors on Tuesday. The brokerage currently has a neutral rating on the stock.

SHL has been the topic of several other research reports. DZ Bank reaffirmed a neutral rating on shares of Siemens Healthineers in a research note on Thursday, August 30th. Citigroup set a €42.50 ($49.42) target price on shares of Siemens Healthineers and gave the stock a buy rating in a research note on Thursday, September 27th. Goldman Sachs Group set a €33.00 ($38.37) target price on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Monday, June 18th. equinet set a €39.00 ($45.35) target price on shares of Siemens Healthineers and gave the stock a buy rating in a research note on Friday, June 15th. Finally, Sanford C. Bernstein set a €41.00 ($47.67) target price on shares of Siemens Healthineers and gave the stock a neutral rating in a research note on Tuesday, September 25th. Fourteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company has an average rating of Hold and an average target price of €38.42 ($44.68).

Shares of SHL opened at €33.90 ($39.42) on Tuesday.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Featured Story: Return on Investment (ROI) Defined, Explained

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.